Emerging whistleblowing risks in pharma and healthcare | Fieldfisher
Skip to main content

Emerging whistleblowing

The recent spread of legislation protecting the actions of 'whistleblowers' and increased regulatory expectations of global corporate accountability, mean that businesses need to adopt a proactive approach to managing allegations or disclosures that point to misconduct within their organisation.

Download our paper that explains why there is an increased risk of whistleblowing for pharma and healthcare businesses and what the latest legal changes and enforcement trends are.